BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Regeneron Pharmaceuticals, Inc. (REGN) Says Its Eye Drug is Taking Roche (RHHBY) Patients


3/14/2012 7:12:43 AM

Regeneron Pharmaceuticals Inc said surveys suggest its Eylea treatment for macular degeneration is capturing 60 percent of its sales from patients that have abandoned Roche Holding AG's Lucentis and Avastin medicines. Regeneron CEO Leonard Schleifer said on Tuesday Eylea has pronounced advantages over Lucentis - Roche's older treatment for the leading cause of blindness among the elderly - including a 45 percent lower annual cost and the need for roughly only half as many injections into the eye. Regeneron shares have more than doubled since Eylea was approved by U.S. regulators on November 18 for the dangerous "wet" form of macular degeneration. More than 200,000 cases of the sight-robbing condition are diagnosed in the United States each year.

Read at Chicago Tribune

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES